{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:15:05Z","timestamp":1762503305539,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,12]],"date-time":"2023-02-12T00:00:00Z","timestamp":1676160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ctro.2023.100597","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T13:02:07Z","timestamp":1676466127000},"page":"100597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4084-4115","authenticated-orcid":false,"given":"Iris","family":"Bartula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anh D.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9317-9526","authenticated-orcid":false,"given":"Anna K.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasnia","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael L.","family":"Morton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan H.","family":"Burmeister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari","family":"Dolven-Jacobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Nobes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2816-2496","authenticated-orcid":false,"given":"John F.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald B.","family":"Fogarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5092-5544","authenticated-orcid":false,"given":"Serigne N","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela M.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2023.100597_b0005","first-page":"215","article-title":"Malignant melanoma: prevention, early detection, and treatment in the 21st century","volume":"50","author":"Rigel","year":"2000","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ctro.2023.100597_b0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/CMR.0000000000000538","article-title":"Incidence and prognosis of brain metastases in cutaneous melanoma patients: a population-based study","volume":"29","author":"Zhang","year":"2019","journal-title":"Melanoma Res"},{"issue":"1","key":"10.1016\/j.ctro.2023.100597_b0015","doi-asserted-by":"crossref","DOI":"10.1186\/s12955-018-0920-0","article-title":"Understanding the quality of life (QoL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire","volume":"16","author":"van Leeuwen","year":"2018","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ctro.2023.100597_b0020","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/pcmr.12647","article-title":"Quality-of-life outcomes in patients with advanced melanoma: A review of the literature","volume":"30","author":"Malkhasyan","year":"2017","journal-title":"Pigment Cell Melanoma Res"},{"issue":"3","key":"10.1016\/j.ctro.2023.100597_b0025","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/cncr.32554","article-title":"Quality-of-life assessment in French patients with metastatic melanoma in real life","volume":"126","author":"Kandel","year":"2020","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.ctro.2023.100597_b0030","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1007\/s11136-020-02520-7","article-title":"Health-related quality of life (QoL) in patients with advanced melanoma receiving immunotherapies in real-world clinical practice settings","volume":"29","author":"Joseph","year":"2020","journal-title":"Qual Life Res"},{"issue":"33","key":"10.1016\/j.ctro.2023.100597_b0035","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1200\/JCO.19.01414","article-title":"Adjuvant Whole-Brain Radiation Therapy compared with observation after local treatment of melanoma brain metastases: A multicenter, randomized phase III trial","volume":"37","author":"Hong","year":"2019","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100597_b0040","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-11-142","article-title":"Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial","volume":"11","author":"Fogarty","year":"2011","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ctro.2023.100597_b0045","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-019-3555-5","article-title":"Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan","volume":"20","author":"Lo","year":"2019","journal-title":"Trials"},{"key":"10.1016\/j.ctro.2023.100597_b0050","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for ue in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"JNCI"},{"issue":"1","key":"10.1016\/j.ctro.2023.100597_b0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00435979","article-title":"The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires","volume":"5","author":"Osoba","year":"1996","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ctro.2023.100597_b0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","article-title":"Interpreting the significance of changes in health-related quality-of-life scores","volume":"16","author":"Osoba","year":"1998","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2023.100597_b0065","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/jdv.15487","article-title":"Quality of life measurement in skin cancer patients: literature review and position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes, Melanoma and Non-Melanoma Skin Cancer","volume":"33","author":"Chernyshov","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ctro.2023.100597_b0070","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1200\/JCO.1995.13.5.1249","article-title":"Test\/retest study of the European Organization for Research and Treamtent Cancer Core Quality of Life Questionnaire","volume":"13","author":"Hrjemstad","year":"1995","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2023.100597_b0075","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF00449426","article-title":"A validation study of the domains of the core EORTC Quality of Life Questionnaire","volume":"2","author":"Niezgoda","year":"1993","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ctro.2023.100597_b0080","doi-asserted-by":"crossref","first-page":"136 -","DOI":"10.1186\/s12955-020-01344-w","article-title":"How is the minimal clinically important difference established in health-related quality of life instruments? Review of anchors and methods","volume":"18","author":"Mouelhi","year":"2020","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ctro.2023.100597_b0085","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation","volume":"41","author":"Norman","year":"2003","journal-title":"Med Care"},{"issue":"6","key":"10.1016\/j.ctro.2023.100597_b0090","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ejca.2010.01.012","article-title":"An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients","volume":"46","author":"Taphoorn","year":"2010","journal-title":"Eur J Cancer"},{"year":"2004","series-title":"Latent variable analysis. The Sage handbook of quantitative methodology for the social sciences","author":"Muth\u00e9n","key":"10.1016\/j.ctro.2023.100597_b0095"},{"key":"10.1016\/j.ctro.2023.100597_b0100","series-title":"Longitudinal Data Analysis","first-page":"143","article-title":"Growth mixture modeling: Analysis with non-Gaussian random effects","author":"Muth\u00e9n","year":"2009"},{"key":"10.1016\/j.ctro.2023.100597_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v078.i02","article-title":"Estimation of Extended Mixed Models Using Latent Classes and Latent Processes: The R Package LCMM","volume":"78","author":"Proust-Lima","year":"2017","journal-title":"Journal Stat Softw"},{"issue":"7","key":"10.1016\/j.ctro.2023.100597_b0110","first-page":"3267","article-title":"Health-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: a longitudinal pilot study","volume":"28","author":"Rogiers","year":"2020","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.ctro.2023.100597_b0115","doi-asserted-by":"crossref","first-page":"e0116440","DOI":"10.1371\/journal.pone.0116440","article-title":"Depression, anxiety and quality of life in long-term survivors of malignant melanoma: a register-based cohort study","volume":"10","author":"Beutel","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ctro.2023.100597_b0120","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/annonc\/mdq255","article-title":"Quality of life in localised malignant melanoma","volume":"21","author":"Schlesinger-Raab","year":"2010","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100597_b0125","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/neuros\/nyw166","article-title":"Quality of life following stereotactic radiosurgery for single and multiple brain metastases","volume":"81","author":"Miller","year":"2017","journal-title":"Neurosurg"},{"issue":"1","key":"10.1016\/j.ctro.2023.100597_b0130","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-020-6559-3","article-title":"The neurocognitive function change criteria after whole-brain radiation therapy for brain metastasis, in reference to health-related quality of life changes: a prospective observation study","volume":"20","author":"Nakano","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctro.2023.100597_b0135","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3171\/2020.4.JNS20788","article-title":"Quality-of-life trajectories after stereotactic radiosurgery for brain metastases","volume":"134","author":"Bunevicius","year":"2020","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ctro.2023.100597_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-019-0917-z","article-title":"Defining Cognitive Reserve and Implications for Cognitive Aging","volume":"19","author":"Pettigrew","year":"2019","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"10.1016\/j.ctro.2023.100597_b0145","first-page":"5","article-title":"The physiology of ageing","volume":"41","author":"Navaratnarajah","year":"2013","journal-title":"The physiology of ageing Medicine"},{"issue":"2","key":"10.1016\/j.ctro.2023.100597_b0150","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archdermatol.2010.433","article-title":"Impact of melanoma on patients' lives among 562 survivors: A Dutch population-based study","volume":"147","author":"Holterhues","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ctro.2023.100597_b0155","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/pon.1889","article-title":"Does psychological adjustment of melanoma survivors differs between genders?","volume":"21","author":"Hamama-Raz","year":"2012","journal-title":"Psychooncology"},{"key":"10.1016\/j.ctro.2023.100597_b0160","first-page":"1","article-title":"Assessing the Educational and Supportive Care Needs of Canadian Metastatic Melanoma Patients and Survivors Attending an Outpatient Clinic","volume":"8","author":"Subasri","year":"2021","journal-title":"J Patient Exp"},{"issue":"1","key":"10.1016\/j.ctro.2023.100597_b0165","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1200\/JCO.2011.41.0639","volume":"31","author":"Soffietti","year":"2013","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2023.100597_b0170","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline","volume":"40","author":"Vogelbaum","year":"2022","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ctro.2023.100597_b0175","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.annonc.2020.07.004","article-title":"ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee","volume":"31","author":"Keilholz","year":"2020","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.ctro.2023.100597_b0180","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1200\/JCO.19.02767","article-title":"Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001","volume":"38","author":"Brown","year":"2020","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ctro.2023.100597_b0185","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1001\/jamaoncol.2022.5049","volume":"8","author":"Palmer","year":"2022","journal-title":"JAMA Oncology"},{"issue":"11","key":"10.1016\/j.ctro.2023.100597_b0190","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0277-9536(99)00045-3","article-title":"Integrating response shift into health-related quality of life research: a theoretical model","volume":"48","author":"Sprangers","year":"1999","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.ctro.2023.100597_b0195","unstructured":"Drug Utilisation Subcomittee (DUSC). Medicines for the treatment of melanoma Australian Governement Department of Health 2018."},{"key":"10.1016\/j.ctro.2023.100597_b0200","first-page":"3489","article-title":"Supportive care and unmet needs in patients with melanoma: a mixed-methods systematic review","volume":"28","author":"Fu","year":"2020","journal-title":"Support Care Cancer"},{"issue":"S2","key":"10.1016\/j.ctro.2023.100597_b0205","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.21037\/apm.2017.06.11","article-title":"Patient preference for stereotactic radiosurgery plus or minus whole brain radiotherapy for the treatment of brain metastases","volume":"6","author":"Zeng","year":"2017","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.ctro.2023.100597_b0210","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1377\/hlthaff.2011.0576","article-title":"Authoritarian physicians and patients' fear of being labeled 'difficult' among key obstacles to shared decision making","volume":"31","author":"Frosch","year":"2012","journal-title":"Health Aff (Millwood)"},{"issue":"9","key":"10.1016\/j.ctro.2023.100597_b0215","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/annonc\/mdv181","article-title":"Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors","volume":"26","author":"Howell","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctro.2023.100597_b0220","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/1472-6963-13-211","article-title":"A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting","volume":"13","author":"Chen","year":"2013","journal-title":"BMC Health Servi Res"},{"key":"10.1016\/j.ctro.2023.100597_b0225","first-page":"41","article-title":"Patient-reported outcome use in oncology: a systematic review of the impact on patient-clinician communication","volume":"26","author":"Yang","year":"2018","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.ctro.2023.100597_b0230","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5694\/mja2.51355","article-title":"Patient-reported outcome measures (PROMs) to guide clinical care: recommendations and challenges","volume":"216","author":"Agarwal","year":"2022","journal-title":"Med J Aust"},{"issue":"4","key":"10.1016\/j.ctro.2023.100597_b0235","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1200\/JOP.2013.001067","article-title":"Review of electronic patient-reported outcomes systems used in cancer clinical care","volume":"10","author":"Jensen","year":"2014","journal-title":"Journal Oncol Pract"},{"key":"10.1016\/j.ctro.2023.100597_b0240","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/pon.4906","article-title":"Patient-reported health-related quality of life outcomes in supportive-care interventions for adults with brain tumors: A systematic review","volume":"28","author":"Pan-Weisz","year":"2019","journal-title":"Psychooncology"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630823000228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630823000228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:12:01Z","timestamp":1762503121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630823000228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":48,"alternative-id":["S2405630823000228"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2023.100597","relation":{},"ISSN":["2405-6308"],"issn-type":[{"type":"print","value":"2405-6308"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2023.100597","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100597"}}